We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$11.1B
AUM Growth
-$771M
(-6.5%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,240
New
103
Increased
332
Reduced
508
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRS
Verso Corporation
VRS
|
+$18.6M |
| 2 |
Designer Brands
DBI
|
+$15.6M |
| 3 |
G-III Apparel Group
GIII
|
+$14.6M |
| 4 |
Alliance Resource Partners
ARLP
|
+$14.4M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$72.7M |
| 2 |
CIR
CIRCOR International, Inc
CIR
|
+$40.1M |
| 3 |
CRAY
Cray, Inc.
CRAY
|
+$26.5M |
| 4 |
Vishay Intertechnology
VSH
|
+$23.6M |
| 5 |
ManpowerGroup
MAN
|
+$23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.26% |
| 2 | Technology | 17.08% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 12.84% |
| 5 | Materials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
601
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.31M | 0.03% |
77,117
-2,727
| -3% | -$106K |
|
|
PATI
602
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $3.31M | 0.03% |
194,864
| – | – |
|
|
SBR
603
Sabine Royalty Trust
SBR
$1.09B
| $3.31M | 0.03% |
68,613
-285
| -0.4% | -$13.8K |
|
604
FerroAtlántica
GSM
$809M
| $3.29M | 0.03% |
1,932,800
+363,900
| +23% | +$693K |
|
|
PRCP
605
DELISTED
Perceptron Inc
PRCP
| $3.26M | 0.03% |
733,580
-142,509
| -16% | -$843K |
|
|
CTLP
606
DELISTED
Cantaloupe
CTLP
| $3.24M | 0.03% |
435,500
-135,000
| -24% | -$836K |
|
|
SWCH
607
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $3.22M | 0.03% |
246,000
+134,000
| +120% | +$1.58M |
|
|
MNRL
608
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $3.22M | 0.03% |
+150,000
| New | +$3.11M |
|
609
NewMarket
NEU
$8.13B
| $3.21M | 0.03% |
8,000
-5,600
| -41% | -$2.32M |
|
610
Utah Medical Products
UTMD
$238M
| $3.18M | 0.03% |
33,247
+2
| +0% | +$168 |
|
|
GBL
611
DELISTED
GAMCO Investors, Inc.
GBL
| $3.17M | 0.03% |
165,446
-108,188
| -40% | -$2.13M |
|
612
BioLife Solutions
BLFS
$1.78B
| $3.16M | 0.03% |
+186,655
| New | +$3.25M |
|
613
Cisco
CSCO
$434B
| $3.15M | 0.03% |
57,500
-5,000
| -8% | -$276K |
|
614
Regenxbio
RGNX
$524M
| $3.08M | 0.03% |
60,000
+31,539
| +111% | +$1.57M |
|
615
Genuine Parts
GPC
$18.1B
| $3.06M | 0.03% |
29,500
+2,500
| +9% | +$259K |
|
616
Distribution Solutions Group
DSGR
$1.61B
| $3.05M | 0.03% |
166,000
+22,000
| +15% | +$377K |
|
617
Chemed
CHE
$6.62B
| $3.04M | 0.03% |
8,420
-1,942
| -19% | -$649K |
|
618
Hanmi Financial
HAFC
$954M
| $3.03M | 0.03% |
136,016
-3,783
| -3% | -$83.9K |
|
619
Vince Holding Corp
VNCE
$109M
| $3.02M | 0.03% |
216,414
-100,831
| -32% | -$1.35M |
|
|
BFYT
620
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.02M | 0.03% |
116,400
-43,000
| -27% | -$1.08M |
|
621
Silicon Laboratories
SLAB
$7.34B
| $3M | 0.03% |
29,000
| – | – |
|
622
Dana Inc
DAN
$3.24B
| $2.99M | 0.03% |
150,031
-392,800
| -72% | -$6.99M |
|
623
Carlyle Group
CG
$14.8B
| $2.97M | 0.03% |
131,200
| – | – |
|
624
Axsome Therapeutics
AXSM
$10.7B
| $2.95M | 0.03% |
114,700
-67,700
| -37% | -$1.36M |
|
625
IDEX
IEX
$16.4B
| $2.94M | 0.03% |
17,100
| – | – |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Royce & Associates held 1,240 positions worth $11.1B, down 6.5% from $11.8B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates withdrew a net $1.01B in Q2 2019, closing 87 positions and reducing 508 holdings. Its most notable exit was Universal Corp, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in G-III Apparel Group worth $12.6M.
- Royce & Associates's largest Q2 2019 buy was G-III Apparel Group: 426,975 shares worth $12.6M.
- Royce & Associates added most to Verso Corporation in Q2 2019, an estimated $18.6M increase.
- Royce & Associates's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $72.7M.
- Royce & Associates fully exited Universal Corp in Q2 2019, selling an estimated $17.7M.
- Royce & Associates's ten largest holdings make up 9.6% of its $11.1B portfolio in Q2 2019.
- Royce & Associates opened 103 new positions and closed 87 in Q2 2019.
- Royce & Associates's portfolio value fell 6.5% quarter-over-quarter to $11.1B.
Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.